Listing is at risk and the usual cures are constrained. Next thing to watch: a reverse-split proxy, a hearings-panel 8-K, or a Form 25. Support side: New 13D filer — insiders or holders bought while this setup is live; see the timeline.
Radar 83 (high attention) · dilution pressure high · listing risk high · governance risk low · runway 0.7 mo · strongest signal: Convertible note (Sep 8, 2026)
What would confirm: Nasdaq 'Pending Suspension' listing, Form 25, hearings-panel denial 8-K, or a reverse-split proxy.
What would prove it wrong: 8-K announcing regained compliance; equity raise that restores stockholders' equity; MVLS back above threshold for 10+ days.
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
Listing is at risk and the usual cures are constrained. Next thing to watch: a reverse-split proxy, a hearings-panel 8-K, or a Form 25. Exchange deficiency plus a structural reason cure is hard (sub-$5M float, negative equity, no cash, or a reverse split already used). Under Nasdaq's 2026 rules (one reverse split per 12 months; $5M MVLS floor with no cure period from Sept 2026) the usual escape hatches are narrower.
Variable-priced paper is outstanding while the listing is under stress — the structure where dilution can accelerate. Watch the share count each quarter. Discount-priced or variable-priced securities are outstanding while the company is managing its listing with reverse splits/notices. Each conversion lowers the price, which lowers the next conversion price.
XCF Global, Inc. (SAFX) filed an NT 10-Q on August 17, 2026, acknowledging the late filing of its Q2 10-Q for the period ending June 30, 2026. The quarterly report itself followed hours later but disclosed a going-concern opinion and liquidity of $1.05 million against current liabilities of $244.8 million as of March 31, 2026. Between August 18 and September 8, 2026, the company entered into at least two convertible note agreements (per 8-Ks), filed three shelf registrations (S-1 on August 19, S-3 on September 10, amended S-3 on September 15) that went effective August 27, and disclosed an at-the-market equity offering program on September 15. On September 14, 2026, the company filed an 8-K disclosing receipt of a Nasdaq minimum-bid deficiency notice, and on September 15 a Schedule 13D was filed by an unidentified third party. The company executed three unregistered securities sales (Item 3.02 8-Ks on August 18, September 14, and September 16) and references to reverse splits appeared in multiple convertible-note exhibits.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 171 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Sep 16, 2026 | ▼ Unregistered sale | 8-K Item 3.02 filed 2026-09-16 (accepted 17:38 ET) filing | 35 |
| Sep 16, 2026 | ▼ Reverse split | “reverse split” language in 8-K (EX-4.1) filed 2026-09-16 filing | 34 |
| Sep 15, 2026 | ▲ New 13D filer | Schedule 13D filed 2026-09-15 filing | 45 |
| Sep 15, 2026 | ▼ ATM program | “atm” language in 8-K (8-K) filed 2026-09-15 filing | 40 |
| Sep 15, 2026 | ▼ ATM program | “atm” language in S-3 (EX-5.1) filed 2026-09-15 filing | 35 |
| Sep 15, 2026 | ▼ Shelf filed | S-3 filed 2026-09-15 filing | 30 |
| Sep 14, 2026 | ▼ Minimum bid deficiency | “min bid” language in 8-K (8-K) filed 2026-09-14 filing | 39 |
| Sep 14, 2026 | ▼ Unregistered sale | 8-K Item 3.02 filed 2026-09-14 (accepted 16:16 ET) filing | 32 |
| Sep 14, 2026 | ▼ Delisting language | “delisting notice” language in 8-K (8-K) filed 2026-09-14 filing | 32 |
| Sep 14, 2026 | ▼ Offering (424B) | 424B3 prospectus supplement 2026-09-14; 19 prior 424B filings in 12m filing | 28 |
| Sep 10, 2026 | ▼ ATM program | “atm” language in S-3 (S-3) filed 2026-09-10 filing | 35 |
| Sep 10, 2026 | ▼ Shelf filed | S-3 filed 2026-09-10 filing | 30 |
| Sep 8, 2026 | ▼ Convertible note | “convertible note” language in 8-K (EX-10.1) filed 2026-09-08 filing | 45 |
| Sep 8, 2026 | ▼ Reverse split | “reverse split” language in 8-K (EX-10.1) filed 2026-09-08 filing | 34 |
| Aug 27, 2026 | ▼ Shelf effective | EFFECT notice 2026-08-27 filing | 21 |
| Aug 19, 2026 | ▼ Shelf filed | S-1 filed 2026-08-19 filing | 30 |
| Mar 31, 2026 | ▼ Runway < 6 months | ~0.7 months runway: liquidity $1,047,539 as of 2026-03-31, burn $17,857,747/yr (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts]) filing | 37 |
| Mar 31, 2026 | ▼ Cash < current liabilities | Liquidity $1,047,539 vs current liabilities $244,838,071 filing | 22 |
AUID authID Inc. · SOBR SOBR Safe, Inc. · DAIC CID Holdco, Inc. · DFLI Dragonfly Energy Holdings Co · SDST Stardust Power Inc. · ADIL ADIAL PHARMACEUTICALS, INC. · screener →